NOTFORDISSEMINATIONIN THEUSORTHROUGH USNEWSWIRESERVICES
The Company will issue an aggregate of [1,380,979] Common Shares at $[0.0675] [based on closing price of
Issuance of the Common Shares is subject to a number of conditions, including receipt of all necessary corporate and regulatory approvals, including the
All securities issued in connection with the Interest Payment will be subject to a statutory hold period of four months plus a day from the date of issuance in accordance with applicable securities legislation.
This news release does not constitute an offer to sell or the solicitation of any offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The Debentures and the Shares which may be issued on exercise thereof have not been and will not be registered under the United States Securities Act of 1933, as amended (the “
About
Sirona’s compounds are licensed to leading companies around the world in return for licensing fees, milestone fees and ongoing royalty payments. Sirona’s laboratory, TFChem, is in
For more information regarding this press release, please contact:
Investor Enquiries:
Email: Info@sironabiochem.com
Neither
Forward Looking Statements
This news release contains forward-looking information, which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Important factors – including the availability of funds and the results of financing efforts, – that could cause actual results to differ materially from the Company’s expectations are disclosed in the Company’s documents filed from time to time on SEDAR (see www.sedarplus.ca). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Source:
2023 GlobeNewswire, Inc., source